| Entry |
|
|---|
| Name |
Pomaglumetad methionil (INN);
LY2140023 |
|---|
| Formula |
C12H18N2O7S2
|
|---|
| Exact mass |
366.0555
|
|---|
| Mol weight |
366.4105
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antipsychotic, Metabotropic glutamate receptor agonist |
|---|
| Comment |
Active form of prodrug: LY404039 [CPD: C21577]
Treatment of schizophrenia
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Metabotropic glutamate receptor family
Glutamate (metabotropic)
GRM2
D10896 Pomaglumetad methionil (INN)
GRM3
D10896 Pomaglumetad methionil (INN)
Prodrugs [br08324.html]
D10896
Prodrugs [br08324.html]
DG02201
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 23
1 C1y C 16.6463 -14.7090
2 C1y C 17.9109 -15.4115
3 C1y C 17.9109 -14.0064
4 C1z C 19.1755 -15.9033
5 C1x C 20.0185 -14.7090
6 S2x S 19.2457 -13.5849
7 C6a C 15.2412 -14.7090
8 O6a O 14.5387 -13.5146
9 O6a O 14.5387 -15.9033
10 N1b N 19.1755 -17.3084
11 C6a C 20.3698 -16.6059
12 O6a O 21.5641 -15.9033
13 O6a O 20.3698 -18.0110
14 C5a C 17.9587 -18.0110
15 O5a O 16.7588 -17.3180
16 C1c C 17.9586 -19.4158
17 C1b C 16.7586 -20.1088
18 N1a N 19.1923 -20.1283
19 C1b C 15.5672 -19.4209
20 S2a S 14.3715 -20.1114
21 C1a C 13.1778 -19.4222
22 O3c O 20.6508 -13.5849
23 O3c O 19.2457 -12.1798
BOND 24
1 1 2 1
2 2 3 1
3 3 1 1
4 2 4 1
5 4 5 1
6 5 6 1
7 3 6 1
8 1 7 1 #Up
9 7 8 1
10 7 9 2
11 4 10 1 #Down
12 4 11 1 #Up
13 11 12 1
14 11 13 2
15 10 14 1
16 14 15 2
17 14 16 1
18 16 17 1
19 16 18 1 #Up
20 17 19 1
21 19 20 1
22 20 21 1
23 6 22 2
24 6 23 2
|
|---|
